MarketInOut Stock Screener Log In | Sign Up
 

Guardant Health Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/05/2026 16:00
Guardant Health Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization23,900 mln
Float129 mln
Earnings Date10/29/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.91
Likely reliable

1-Year Forecast

197.44
Modest upside

Relative Strength

92 / 100
Top performer

Pre-Tax Margin

-38%
Deeply loss-making

ROE

211
Extraordinary

Business Description

Guardant Health is a cancer diagnostics company founded in 2011 and based in Palo Alto, California, that develops blood and tissue tests to detect and analyze cancer. Its products help doctors identify genetic changes in tumors, guiding treatment decisions for patients, and also include a blood test designed to screen healthy adults for colorectal cancer. The company additionally supports pharmaceutical research by offering data, software tools, and services that help connect patients with relevant clinical trials and advance the development of new cancer therapies.

Key Fundamentals

EPS-3.51
ROE211
RPS9.14
ROIC-67.98
ROA-26.83
Interest Cover-97.65
EBITDA, mln-411
EV / EBITDA-59.50
EV / EBIT-54.41
Revenue, mln1,183
EV / Revenue20.68

Quote Details

Last 187.22
Change 9.42 (5.3%)
Open 177.45
Volume 1,736,240
Turnover 325,058,848
Average Volume 1,825,203

Financial Ratios

Pre-Tax Profit Margin-38
Current Ratio4.03
Price / Sales19.51

Financial Strength

Altman Z-Score4.83
Piotroski F-Score 4 / 9
Beneish M-Score-2.91
1-Year Target Price197.44
Short Ratio5.70
Short % of Float8.56

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.58% 89 / 100   
1 Month 16.26% 93 / 100   
2 Months 21.78% 91 / 100   
6 Months 109% 97 / 100   
1 Year 205% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us